Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model

Hepatology Research

Volumn 18, Issue 1, 2000, Pages 72-85

  Labonté, Patrick ^a   Kadhim, Salam ^b   Bowlin, Terry ^a   Mounir, Samir ^a  

^a Shire Canada   (Canada)

^b Stressgen Biotechnologies Co   (Canada)

Author keywords

Animal model; Antitumoral agent; Doxorubicin; Hepatocellular carcinoma; Huh 7

Indexed keywords

DOXORUBICIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CELL CLONING; CONTROLLED STUDY; DRUG SCREENING; GROWTH RATE; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0034112215     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00087-X     Document Type: Article

References (29)

1. Bosch X.F. Global epidemiology of hepatocellular carcinoma. Okuda K., Tabor E. Liver Cancer. 1998;13-28 Churchill Livingstone, New York.
2. Koshy R., Meyer M. Oncogenicity of hepatitis B virus. Rev. Med. Virol. 2:1992;131-140.
3. Alter M.J. Epidemiology of hepatitis C in the west. Semin. Liver Dis. 15:1995;5-14.
4. Colombo M. Treatment of hepatocellular carcinoma. J. Viral. Hepat. 4:1997;125-130.
5. Delbeke D., Martin W.H., Sandler M.P., Chapman W.C., Wright J.K., Pinson C.W. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch. Surg. 133:1998;510-515.
6. Horigome H., Nomura T., Saso K., Itoh M. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am. J. Gastroenterol. 94:1999;1914-1917.
7. Lohmann R., Bechstein W.O., Langrehr J.M. et al. Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation. Transplant Proc. 27:1995;1245-1246.
8. Ojogho O.N., So S.K., Keeffe E.B. et al. Orthotopic liver transplantation for hepatocellular carcinoma; factors affecting long-term patient survival. Arch. Surg. 131:1996;935-939.
9. Figueras J., Jaurrieta E., Valls C. et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 25:1997;1485-1489.
10. Wang X., Fu X., Brown P.D., Crimmin M.J., Hoffman R.M. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54:1994;4726-4728.
11. Furukawa T., Fu X., Kubota T., Watanabe M., Kitajima M., Hoffman R.M. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res. 53:1993;1204-1208.
12. Fu X., Guadagni F., Hoffman R.M. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc. Natl. Acad. Sci. USA. 89:1992;5645-5649.
13. Fu X., Hoffman R.M. Human RT-4 bladder carcinoma is highly metastatic in nude mice and comparable to ras-H-transformed RT-4 when orthotopically implanted as histologically intact tissue. Int. J. Cancer. 51:1992;989-991.
14. Sakakibara T., Chen F.A., Kida H. et al. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug of drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. Cancer Res. 56:1996;3743-3746.
15. Fu X., Hoffman R.M. A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Res. 13:1993;901-904.
16. Fu X., Hoffman R.M. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 13:1993;283-286.
17. Fu X., Herrera H., Hoffman R.M. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer. 52:1992;987-990.
18. Sun F.X., Tang Z.Y., Liu K.D. et al. Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically patient specimens. J. Cancer Res. Clin. Oncol. 122:1996;397-402.
19. Grove K.L., Guo X., Liu S.H., Gao Z., Chu C.K., Cheng Y.C. Anticancer activity of β-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L conformation. Cancer Res. 55:1995;3008-3011.
20. Yao Z., Zhou Y., Feng X., Chen C., Guo J. In vivo inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides in athymic nude mice. J. Viral. Hepat. 3:1996;19-22.
21. Wang Z.F., Stein R., Sharkey R.M., Goldenberg D.M. Carcinoembryonic antigen and α-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model. Cancer Res. 50:1990;8698-8728.
22. Knowles B.B., Howe C.C., Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209:1980;497-499.
23. Shouval D., Schuger L., Levij I.S., Reid L.M., Neeman Z., Shafritz D.A. Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice. Virchows Archiv. A, Pathol. Anat. Histopathol. 412:1988;595-606.
24. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42:1982;3858-3863.
25. Sasaki K., Ogino T., Kawasaki S., Okita K., Takemoto T., Takahashi M. Distribution of α-fetoprotein-producing cells and proliferating cells in human hepatoma cells transplanted into athymic mice. Tumor Biol. 8:1987;181-185.
26. Moore S.W., Hesseling P.B., Wessels G., Schneider J.W. Hepatocellular carcinoma in children. Pediatr. Surg. Int. 12:1997;266-270.
27. Ryder S.D., Rizzi P.M., Metivier E., Karani J., Williams R. Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut. 38:1996;125-128.
28. Cay O., Kruskal J.B., Nasser I., Thomas P., Clouse M.E. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin. Radiology. 205:1997;95-101.
29. Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.